Gene therapy stocks slammed after scientist reveals safety concerns … – MarketWatch
MarketWatch |
Gene therapy stocks slammed after scientist reveals safety concerns …
MarketWatch Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Biosciences Inc.’s scientific advisory board. New study shows severe toxicity with high-dose AAV9-based gene therapy in animal modelsEurekAlert (press release) Gene therapy pioneer James Wilson sounds an alarm on high-dose …Endpoints News Gene Therapy May Not Be a Viable Option for Many Patients | GENGenetic Engineering & Biotechnology News Barron’s –STAT –Seeking Alpha all 9 news articles » |
MarketWatch |
Gene therapy stocks slammed after scientist reveals safety concerns …
MarketWatch Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Biosciences Inc.’s scientific advisory board. New study shows severe toxicity with high-dose AAV9-based gene therapy in animal modelsEurekAlert (press release) Gene therapy pioneer James Wilson sounds an alarm on high-dose …Endpoints News Gene Therapy May Not Be a Viable Option for Many Patients | GENGenetic Engineering & Biotechnology News Barron’s –Seeking Alpha all 9 news articles » |
BioPharma-Reporter.com |
UCL to harness Synpromics’ promotors in gene therapy collaboration
BioPharma-Reporter.com In gene therapy, synthetic promotors – used to regulate gene activity and precisely control protein production – deliver therapeutic genes to immune cells such as microglia, macrophages, and T-cells. Synpromics said the research collaboration provides … |
BioPharma-Reporter.com |
UCL to harness Synpromics’ promotors in gene therapy collaboration
BioPharma-Reporter.com In gene therapy, synthetic promotors – used to regulate gene activity and precisely control protein production – deliver therapeutic genes to immune cells such as microglia, macrophages, and T-cells. Synpromics said the research collaboration provides … |